GSK plc reports results for the quarter ended September 30 - Earnings Summary

• GSK plc GSK.L reported quarterly adjusted earnings of 55 pence​​ per share for the quarter ended September 30, identical to the same quarter last year. The mean expectation of nine analysts for the quarter was for earnings of 51 pence per share. Wall Street expected results to range from 50 pence to 53 pence per share.

• Revenue rose 4% to £8.89 billion from a year ago; analysts expected £8.82 billion.

• GSK plc's reported EPS for the quarter was 39 pence​.

• The company reported quarterly net income of £1.54 billion.

• GSK plc shares had risen by 5.0% this quarter and gained 5.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 3.7% in the last three months.​

• In the last 30 days, three analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 9 "strong buy" or "buy," 14 "hold" and 3 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."

• Wall Street's median 12-month price target for GSK plc is GBp2,100.00, about 8.4% above its last closing price of GBp1,923.50

This summary was machine generated from LSEG data October 28 at 08:37 a.m. UTC. ​All figures in pounds unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)